Unknown

Dataset Information

Hippocampal blood-brain barrier of methamphetamine self-administering HIV-1 transgenic rats.


ABSTRACT: Combined antiretroviral therapy for HIV infection reduces plasma viral load and prolongs life. However, the brain is a viral reservoir, and pathologies such as cognitive decline and blood-brain barrier (BBB) disruption persist. Methamphetamine abuse is prevalent among HIV-infected individuals. Methamphetamine and HIV toxic proteins can disrupt the BBB, but it is unclear if there exists a common pathway by which HIV proteins and methamphetamine induce BBB damage. Also unknown are the BBB effects imposed by chronic exposure to HIV proteins in the comorbid context of chronic methamphetamine abuse. To evaluate these scenarios, we trained HIV-1 transgenic (Tg) and non-Tg rats to self-administer methamphetamine using a 21-day paradigm that produced an equivalency dose range at the low end of the

SUBMITTER: Ohene-Nyako M 

PROVIDER: S-EPMC9949894 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature